- Home
- SSRM vs AVBP Comparison
SSRM vs AVBP Comparison
Compare SSRM & AVBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSRM
- AVBP
- Stock Information
- Founded
- SSRM 1946
- AVBP 2021
- Country
- SSRM United States
- AVBP United States
- Employees
- SSRM N/A
- AVBP N/A
- Industry
- SSRM Precious Metals
- AVBP
- Sector
- SSRM Industrials
- AVBP
- Exchange
- SSRM Nasdaq
- AVBP NYSE
- Market Cap
- SSRM 2.2B
- AVBP 862.8M
- IPO Year
- SSRM 1996
- AVBP 2024
- Fundamental
- Price
- SSRM $12.76
- AVBP $21.63
- Analyst Decision
- SSRM Hold
- AVBP Strong Buy
- Analyst Count
- SSRM 3
- AVBP 8
- Target Price
- SSRM $10.53
- AVBP $38.38
- AVG Volume (30 Days)
- SSRM 2.8M
- AVBP 484.4K
- Earning Date
- SSRM 08-05-2025
- AVBP 08-13-2025
- Dividend Yield
- SSRM N/A
- AVBP N/A
- EPS Growth
- SSRM N/A
- AVBP N/A
- EPS
- SSRM 0.42
- AVBP N/A
- Revenue
- SSRM $1,082,002,000.00
- AVBP N/A
- Revenue This Year
- SSRM $40.21
- AVBP $85.82
- Revenue Next Year
- SSRM $19.05
- AVBP N/A
- P/E Ratio
- SSRM $30.24
- AVBP N/A
- Revenue Growth
- SSRM N/A
- AVBP N/A
- 52 Week Low
- SSRM $4.32
- AVBP $15.47
- 52 Week High
- SSRM $13.48
- AVBP $36.37
- Technical
- Relative Strength Index (RSI)
- SSRM 53.55
- AVBP 47.74
- Support Level
- SSRM $12.15
- AVBP $19.71
- Resistance Level
- SSRM $13.48
- AVBP $22.32
- Average True Range (ATR)
- SSRM 0.49
- AVBP 1.32
- MACD
- SSRM -0.08
- AVBP -0.20
- Stochastic Oscillator
- SSRM 49.65
- AVBP 31.89
About SSRM SSR Mining Inc.
SSR Mining Inc is a minerals company focused on mining precious metals in the Americas. More than half of Silver Standard's revenue is attributable to the production of gold, with a key portion derived from silver production. The company owns and operates the Marigold mine in Nevada, United States; the Seabee Gold Operation in Saskatchewan, Canada; and the Puna mine in Argentina. The majority of gold production is derived from the Marigold mine, and Silver Standard's silver production is principally derived from the Puna mine.
About AVBP ARRIVENT BIOPHARMA INC
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.